MAPT and Alzheimer disease: Alzheimer’s disease (AD) is a chronic progressive neurodegenerative disease characterized by the accumulation of amyloid-β protein and a Tau-meditated neuronal injury (de Paula et al., 2009; de-Paula et al., 2012).